[PulmOne in The Times of Israel] Portable lung tests help patients breathe easier
Israeli startup PulmOne doubles its revenue by bringing hospital-quality pulmonary exams to doctors’ offices Read...
Read MoreFeb 21, 2022 | News Center, Newsticker
Israeli startup PulmOne doubles its revenue by bringing hospital-quality pulmonary exams to doctors’ offices Read...
Read MoreApr 1, 2020 | News Center
6 OurCrowd portfolio companies were featured in Start-Up Nation Central’s HealthTech COVID-19 map of Israeli medtech companies fighting coronavirus. See the...
Read MoreMar 23, 2020 | Tech & Startups
The reality of the corona crisis for startup companies – and really any business – is that they need to stay as relevant as possible in this new, uncharted environment. Many of the long term trends that were evident before the crisis such as distance learning, working from home, or e-commerce, are now reaching an inflection point. These trends have been accelerated beyond belief in the last few weeks and a snap back to the prior status quo seems unlikely once this crisis is over. It is doubtful that brick and mortar stores will regain much of the market share they’ve lost to online e-commerce before the crisis began. There are going to be long term systematic changes as a result of the change in behavior, from telehealth and medtech to vaccines and early warning, OurCrowd portfolio companies are helping combat the corona crisis and are already gearing up to fight the next pandemic. Technologies for fighting pandemics are not just trendy hype. The reality is, pandemics are here to stay, and the global community needs to be ready for...
Read MoreMar 19, 2020 | News Center, Newsticker
Many of the startups that can help defeat the coronavirus are based in Israel or are part of the portfolios of Israeli VCs. From diagnosis, mitigation, patient tracking, contamination prevention, and protecting medical staff, to education and exercise for the homebound. Read...
Read MoreNov 7, 2019 | News Center
PulmOne USA Inc. has entered into a partnership agreement with Circassia Pharmaceuticals to offer the NIOX VERO fractional exhaled nitric oxide (FeNO) airway inflammation measurement system as an integrated add-on to PulmOne’s MiniBox+. Read...
Read More